TrialBlood advances2023

The safety and efficacy of N8-GP (turoctocog alfa pegol) in previously untreated pediatric patients with hemophilia A.

Christoph Male et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.